[Journal logo]

Volume 69 
Part 2 
Pages m83-m84  
February 2013  

Received 17 December 2012
Accepted 21 December 2012
Online 9 January 2013

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.004 Å
R = 0.026
wR = 0.069
Data-to-parameter ratio = 20.0
Details
Open access

Di-[mu]-thiosemicarbazide-[kappa]4S:S-bis[chloridobis(triphenylphosphane-[kappa]P)silver(I)]

aDepartment of Chemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand, and bDepartment of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand
Correspondence e-mail: yupa.t@psu.ac.th

The dinuclear title complex, [Ag2Cl2(CH5N3S)2(C18H15P)2], lies across an inversion center. The AgI ion exhibits a slightly distorted tetrahedral coordination geometry formed by a P atom from a triphenylphosphane ligand, two metal-bridging S atoms from thiosemicabazide ligands and one chloride ion. The S atoms bridge two symmetry-related AgI ions, forming a strictly planar Ag2S2 core with an Ag...Ag separation of 2.7802 (7) Å. There is an intramolecular N-H...Cl hydrogen bond. In the crystal, N-H...Cl and N-H...S hydrogen bonds link complex molecules, forming layers parallel to (001). These layers are connected through [pi]-[pi] stacking interactions [centroid-centroid distance = 3.665 (2) Å], leading to the formation of a three-dimensional network.

Related literature

For metal(I) complexes of phosphine ligands as precursors for the preparation of mixed-ligand complexes, see: Ferrari et al. (2007[Ferrari, M. B., Bisceglie, F., Cavalli, E., Pelosi, G., Tarasconi, P. & Verdolino, V. (2007). Inorg. Chim. Acta, 360, 3233-3240.]); Pakawatchai et al. (2012[Pakawatchai, C., Jantaramas, P., Mokhagul, J. & Nimthong, R. (2012). Acta Cryst. E68, m1506-m1507.]). For potential applications of thiosemicarbazide derivatives and their metal complexes, see: Pandeya et al. (1999[Pandeya, S. N., Sriram, D., Nath, G. & DeClercq, E. (1999). Eur. J. Pharm. Sci. 9, 25-31.]); Wujec et al. (2009[Wujec, M., Stefanska, J., Siwek, A. & Tatarczak, M. (2009). Acta Polon. Pharm. Drug Res. 66, 73-82.]); Mohareb & Mohamed (2012[Mohareb, R. M. & Mohamed, A. A. (2012). Int. J. Pure. Appl. Chem. 2, 144-155.]); He et al. (2012[He, J., Wang, X., Zhao, X., Liang, Y., He, H. & Fu, L. (2012). Eur. J. Med. Chem. 54, 925-930.]). For examples of related discrete complexes, see: Wattanakanjana et al. (2012[Wattanakanjana, Y., Pakawatchai, C., Kowittheeraphong, S. & Nimthong, R. (2012). Acta Cryst. E68, m1572-m1573.]); Lobana et al. (2008[Lobana, T. S., Sharma, R. S. & Butcher, R. J. (2008). Polyhedron, 27, 1375-1380.]).

[Scheme 1]

Experimental

Crystal data
  • [Ag2Cl2(CH5N3S)2(C18H15P)2]

  • Mr = 993.46

  • Triclinic, [P \overline 1]

  • a = 8.7845 (4) Å

  • b = 9.4656 (4) Å

  • c = 13.7529 (6) Å

  • [alpha] = 109.276 (1)°

  • [beta] = 98.306 (1)°

  • [gamma] = 99.739 (1)°

  • V = 1038.94 (8) Å3

  • Z = 1

  • Mo K[alpha] radiation

  • [mu] = 1.28 mm-1

  • T = 293 K

  • 0.38 × 0.30 × 0.10 mm

Data collection
  • Bruker SMART CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2003[Bruker (2003). SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.638, Tmax = 0.880

  • 14302 measured reflections

  • 5026 independent reflections

  • 4627 reflections with I > 2[sigma](I)

  • Rint = 0.036

Refinement
  • R[F2 > 2[sigma](F2)] = 0.026

  • wR(F2) = 0.069

  • S = 1.06

  • 5026 reflections

  • 251 parameters

  • 5 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.38 e Å-3

  • [Delta][rho]min = -0.55 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N3-H3B...Cl1i 0.87 (2) 2.67 (2) 3.535 (2) 171 (2)
N2-H2...S1ii 0.83 (2) 2.66 (2) 3.4320 (15) 155 (2)
N1-H1B...Cl1iii 0.85 (2) 2.63 (2) 3.4088 (16) 154 (2)
N1-H1A...Cl1 0.89 (2) 2.45 (2) 3.3239 (16) 170 (2)
Symmetry codes: (i) x-1, y, z; (ii) -x+1, -y+2, -z+1; (iii) -x+2, -y+3, -z+1.

Data collection: SMART (Bruker, 1998[Bruker (1998). SMART. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2003[Bruker (2003). SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: Mercury (Macrae et al., 2008[Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.]); software used to prepare material for publication: SHELXL97 and publCIF (Westrip, 2010[Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: LH5573 ).


Acknowledgements

We gratefully acknowledge financial support from the Center for Innovation in Chemistry (PERCH-CIC), the Commission on Higher Education, Ministry of Education, the Department of Chemistry and the Graduate School, Prince of Songkla University.

References

Bruker (1998). SMART. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2003). SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Ferrari, M. B., Bisceglie, F., Cavalli, E., Pelosi, G., Tarasconi, P. & Verdolino, V. (2007). Inorg. Chim. Acta, 360, 3233-3240.  [ISI] [CSD] [CrossRef]
He, J., Wang, X., Zhao, X., Liang, Y., He, H. & Fu, L. (2012). Eur. J. Med. Chem. 54, 925-930.  [ISI] [CrossRef] [ChemPort] [PubMed]
Lobana, T. S., Sharma, R. S. & Butcher, R. J. (2008). Polyhedron, 27, 1375-1380.  [ISI] [CrossRef] [ChemPort]
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.  [ISI] [CrossRef] [ChemPort] [details]
Mohareb, R. M. & Mohamed, A. A. (2012). Int. J. Pure. Appl. Chem. 2, 144-155.
Pakawatchai, C., Jantaramas, P., Mokhagul, J. & Nimthong, R. (2012). Acta Cryst. E68, m1506-m1507.  [CSD] [CrossRef] [details]
Pandeya, S. N., Sriram, D., Nath, G. & DeClercq, E. (1999). Eur. J. Pharm. Sci. 9, 25-31.  [ISI] [CrossRef] [PubMed] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Wattanakanjana, Y., Pakawatchai, C., Kowittheeraphong, S. & Nimthong, R. (2012). Acta Cryst. E68, m1572-m1573.  [CSD] [CrossRef] [details]
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.  [ISI] [CrossRef] [ChemPort] [details]
Wujec, M., Stefanska, J., Siwek, A. & Tatarczak, M. (2009). Acta Polon. Pharm. Drug Res. 66, 73-82.  [ChemPort]


Acta Cryst (2013). E69, m83-m84   [ doi:10.1107/S1600536812051562 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.